Treatments for Depression
Recent Research including DCRP clinicians.Click on study title link to view abstract (appears in new window)
Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.
Fava M, Alpert J, Nierenberg A, Lagomasino I, Sonawalla S, Tedlow J, Worthington J, Baer L, Rosenbaum JF.
Treatment Approaches to Major Depressive Disorder Relapse. part 2: reinitiation of antidepressant treatment.
Fava M, Schmidt ME, Zhang S, Gonzales J, Raute NJ, Judge R.
Treatment Approaches to Major Depressive Disorder Relapse. part 1: dose increase.
Schmidt ME, Fava M, Zhang S, Gonzales J, Raute NJ, Judge R.
Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial. Sonawalla SB, Farabaugh AH, Leslie VM, Pava JA, Matthews JD, Fava M.
Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial. Sonawalla SB, Farabaugh AH, Leslie VM, Pava JA, Matthews JD, Fava M.
Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia. Fava M, Hoog SL, Judge RA, Kopp JB, Nilsson ME, Gonzales JS.
Use of the Chinese version of the Beck Depression Inventory for screening depression in primary care.Yeung A, Howarth S, Chan R, Sonawalla S, Nierenberg AA, Fava M.
A survey of prescribing practices in the treatment of depression. Petersen T, Dording C, Neault NB, Kornbluh R, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M.
NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients. Petersen T, Papakostas GI, Bottonari K, Iacoviello B, Alpert JE, Fava M, Nierenberg AA.
Switching to bupropion in fluoxetine-refractory depression. Fava M, Papakostas GI, Petersen T, Mahal Y, Quitkin F, Stewart J, McGrath P.
Management of major depression in the primary care setting. Mischoulon D, McColl R, Howarth S, Lagomasino IT, Alpert JE, Nierenberg AA, Fava M.
An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor binding. Mischoulon D, Dougherty DD, Bottonari KA, Gresham RL, Sonawalla SB, Fischman AJ, Fava M.